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Background: The last decade has witnessed a rapid transformation in the role boundaries of the allied health
professions, enabled through the creation of new roles and the expansion of existing, traditional roles. A strategy
of health care ‘modernisation’ has encompassed calls for the redrawing of professional boundaries and identities,
linked with demands for greater workforce flexibility. Several tasks and roles previously within the exclusive domain
of medicine have been delegated to, or assumed by, allied health professionals, as the workforce is reshaped to
meet the challenges posed by changing demographic, social and political contexts. The prescribing of medicines
by non-medically qualified healthcare professionals, and in particular the podiatry profession, reflects these
changes.
Methods: Using a range of key primary documentary sources derived from published material in the public
domain and unpublished material in private possession, this paper traces the development of contemporary UK
and Australasian podiatric prescribing, access, supply and administration of medicines. Documentary sources
include material from legislative, health policy, regulatory and professional bodies (including both State and Federal
sources in Australia).
Results: Tracing a chronological, comparative, socio-historical account of the emergence and development of
‘prescribing’ in podiatry in both Australasia and the UK enables an analysis of the impact of health policy reforms
on the use of, and access to, medicines by podiatrists. The advent of neo-liberal healthcare policies, coupled with
demands for workforce flexibility and role transfer within a climate of demographic, economic and social change
has enabled allied health professionals to undertake an expanding number of tasks involving the sale, supply,
administration and prescription of medicines.
Conclusion: As a challenge to medical dominance, these changes, although driven by wider healthcare policy,
have met with resistance. As anticipated in the theory of medical dominance, inter-professional jurisdictional
disputes centred on the right to access, administer, supply and prescribe medicines act as obstacles to workforce
change. Nevertheless, the broader policy agenda continues to ensure workforce redesign in which podiatry has
assumed wider roles and responsibilities in prescribing.
Introduction
Recent health policy reforms, underpinned by the
‘ongoing influence of a neo-liberal and managerialist
agenda’, have clearly enabled an extension in the role
boundaries of the allied health professions (AHPs) in
both the UK and Australasia [1,2]. In the past, parame-
dical advances in prescribing of medicines had been
largely constrained through the exercise of medical
power, often described as professional autonomy [3-5].
Professional autonomy has been widely explored in rela-
tion to the medical and allied health professions [6,7].
In broad terms, professional autonomy is taken to repre-
sent the ‘legitimated control that an occupation exer-
cises over the organisation and terms of its work’[6].
Medicine has often been considered as an exemplar of
the autonomous profession, characterised by its author-
ity, and hegemony over the other health professions
[2,4,6,8-11]. Several explanations have been provided to
indicate the way in which medical professionalism was
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control over the knowledge base, role boundaries and
status of other healthcare professions [7,12-18]. The
concept of medical dominance was instrumental in cap-
turing the establishment of hegemonic authority by
medicine within a hierarchical arrangement of power in
healthcare [4,7,10,14,16,19]. One aspect of this theory
has been subject to criticism, however. It appears to
accept as inescapable the submission of other healthcare
professions to medical hegemony, without acknowled-
ging their own aspirations [14,16,17]. Indeed, evidence
continues to accumulate which suggests a fundamental
shift in medical dominance [1,11,20-24]. Larkin [17]
examined the case for a significant transition in inter-
professional relations towards co-equal partnerships, in
a shifting profession-state arena. Now, government
reforms are thought to ‘encourage’ a ‘new type of pro-
fessionalism - that is not based upon exclusion, control
and special status’. Nevertheless, evidence for any signif-
icant displacement of medical dominance remains elu-
sive in the absence of any identifiable alternative, in
spite of the rhetoric of modernisation [17].
Healthcare policy and reorganisation in both Australa-
s i aa n dt h eU Kh a sb e e nt a k e nt oi n d i c a t ead e c l i n ei n
medical dominance, particularly over the last two to
three decades [1,2,17,20,25,26]. One central feature of
the dominance of medicine has been the near exclusive
right to prescribe medicines. In both Australasia and the
UK legislation has, for many years, recognised medicine
(and dentistry) as sole recipients of the right to access,
administer, supply and prescribe from a full range of
available medicines, justified on the basis of the special
knowledge, education and skill of the profession. Other
healthcare professions, such as nursing and the allied
health professions, initially excluded, have gradually
been able to secure increasing rights to access, supply,
administer and finally prescribe medicines, against a
backdrop of medical resistance [27]. By tracing the
emergence and development of allied health ‘prescrib-
ing’, from early rights to administer and supply certain
restricted category medicines, to the more recent forms
of actual prescribing, it is possible to map the changing
relationships between the profession of medicine, gov-
ernment and the allied health professions.
In this paper, podiatry will serve as a case exemplar.
In light of its long engagement with medicine and gov-
ernment Health Departments over the right to use
restricted category medicines, it enables a socio-histori-
cal account to be constructed which adequately illus-
trates the gradual impact on the profession of changing
health policy reform as a response to wider challenges
to the provision of healthcare in both Australasia and
the UK.
Methods
This data in this paper were constructed from a range
of documentary data sources, primarily derived from
published sources in the public domain, supported by
access to unpublished material in private possession.
Policy documents, consultation papers, minutes of
meetings, press releases, publications from professional
and regulatory bodies and legislative sources were
included. Documents were sourced from within Austra-
lasia and the UK, including both State and Federal
sources in Australia. These data were used to construct
a socio-historical account of the development of con-
temporary UK and Australasian podiatric access, supply,
administration and prescription of medicines, grounded
in a health policy context. Theory derived from the
sociology of the professions underpinned the socio-his-
torical analysis.
Results
AHP prescribing in the UK and Australasia
Whilst formal prescribing by non-medically qualified
allied health professionals is a new and fairly limited
phenomenon in both the UK and Australasia, several of
the smaller professions, most notably podiatrists and
optometrists, have been accustomed to exercising legal
rights to access, supply, administer and sell a restricted
range of medicines over several decades [28-38]. In
other cases, such as physiotherapy and radiography,
legal rights to the supply or administration of restricted
category medicines have either been available only since
2005 (in the UK), or, in the case of Australian phy-
siotherapy, not yet recognised [39,40]. Where rights do
exist, the mode of use is often different, ranging from
specialist practitioners working in fields such as mus-
culo-skeletal care (in the case of physiotherapy) to more
general use, as in the case of podiatry [28,41].
From a socio-historical viewpoint, since the 1960s, the
emergence of supply and administration rights to certain
restricted medicines, in the wake of changing legislation,
might well be viewed as part of the broader ‘professional
project’ of podiatrists, optometrists and others, and cen-
tral to their desire to confirm professional autonomy
and independence in practice [33,42]. Podiatry and
optometry have, in the past, been distinguished from
other allied health professions on the grounds of their
independence from hospital practice, and thus relative
freedom from immediate supervision by the medical
profession [14].
Radiography and physiotherapy, conversely, emerged
more clearly as hospital employees working in direct
support of the medical profession, on a daily basis [14].
It is also clear that not all allied health professions are
likely to become active prescribers, or aim to secure
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possibly such as arts therapists.
In order to adequately understand the effect of man-
agerialist health policy reforms on the transition in
podiatric role boundaries, it is necessary to trace the
chronological context of change. As a result, the context
of podiatric prescribing must take into account the
broader privileges associated with the legal right to
access, administer, sell and supply specified medicines
that are otherwise restricted (that is, those that fall
within in the ‘prescription only’ and ‘pharmacy only’
categories of medicine in the UK and New Zealand, and
those within the Schedule 3,4 and 8 categories in Aus-
tralia), as well as the actual ‘prescribing’ mechanisms
involved in ‘supplementary’ and ‘independent’ versions
[43], or the recent freedom granted in Victoria (Austra-
lia) to podiatrists under the Health Professions Registra-
tion Act of 2005.
In the UK, prior to the advent of supplementary pre-
scribing or patient group directions podiatrists had
‘accessed’, ‘supplied/sold’ and ‘administered’ restricted
category medicines through authority granted by statu-
tory instruments. A statutory instrument is a form of
‘delegated’ legislation, allowing exemptions to be made
to the provisions of established ‘primary’ legislation (in
this case the Medicines Act of 1968), without the need
to repeal the entire Act [44]. Similarly, in Australia
amendments to State or Territory legislation, such as
the Health (Drugs & Poisons) Regulation 1996 (Queens-
land), grants the profession specific rights under the
authorisation of the Health Minister.
Medicines and the allied health professions:
a socio-historical context
1. The UK
I nt h ee a r l y1 9 6 0 s ,p u b l i cc o n f i d e n c ei nh e a l t h c a r ew a s
undermined by the unforeseen complications arising
from the use of the approved medicine thalidomide
(causing teratogenic deformities in the offspring of
women pregnant during the drug treatment) and
resulted in a major review of the adequacy of existing
medicines legislation [45,46].N e w ,u n i f y i n g ,l e g i s l a t i o n
designed to supercede the existing provisions was put in
place, covering several features, such as the manufac-
ture, and marketing or licensing of medicines, alongside
new mechanisms for regulating access, administration,
sale and supply [28,46].
A Medicines Commission was also established, with a
remit which included a role in determining whether
submissions for exemptions by professional groups
excluded under the new legislation (The Medicines Act
1968) would be accepted or rejected [28]. Under the
new system, medicines were classified as ‘prescription
only’, ‘pharmacy only’ or ‘general sales list’. ‘Prescription
only’ medicines were available only to ‘appropriate
practitioners’, who were identified as doctors of medi-
cine, dentists and veterinary practitioners (Part III of the
1968 Act). However, podiatrists had already been using
several medicines caught up in the re-classification, and
found they no longer had rights to their use. As a result,
the profession was forced to utilise the new arrange-
ments, and seek legally recognised exemptions to gain
access to medicines already part of normative practice -
arrangements which proved difficult to navigate without
opposition.
Within a decade, the political landscape began to
change dramatically, as policy reforms throughout the
1980s gradually made possible greater access to
restricted medicines. By the mid-1980s the Thatcher
Government, a neo-liberal, market oriented conservative
administration, introduced a series of reforms which
impacted directly on the autonomy of the medical pro-
fession and its exclusivity in the delivery of certain ser-
vices, including the supply of medicines [47,48]. First,
‘indicative’ prescribing was introduced, limiting doctors
prescribing habits in the interests of fiscal probity, whilst
acting to diminish medical power [49]. Within a short
time, plans to grant specialist nurses and midwives
enhanced ‘prescribing’ rights were unveiled [50,51].
Nevertheless, these changes did not mean progress
towards AHP prescribing would be unproblematic. On
the contrary, role boundary disputes arose, creating
obstacles to change [28,50-52]. Yet, by 1999 a new pol-
icy direction was announced in the ‘Crown Report’
review of non-medical prescribing, which was rapidly
accepted by Government [43]. Pressure for change
stemmed from a number of converging dilemmas facing
t h ef u t u r eo fh e a l t hc a r ep r o v i s i o n ;a na g e i n gp o p u l a -
tion, changing disease profiles and a reduced workforce,
coupled with a looming crisis in healthcare recruitment
and retention, fiscal constraint and the challenge of Eur-
opean Union Working Time Directives. A new policy
agenda emphasising new ways of working, role substitu-
tion and workforce redesign emerged [53-58]. Key nurse
and allied health professional groups would, it was envi-
sioned, emerge as genuine ‘prescribers’ [43]. Two new
categories of prescriber were defined - ‘independent’ and
‘dependent’ (later ‘supplementary’), reflecting a new level
of autonomy for selected allied health professionals.
Independent prescriber status was suggested as possible
for five named professional groups, including extended
scope physiotherapists, optometrists and podiatrists. In
the year following the Crown report, group protocol
arrangements were given full legal status, ensuring
another formal route to attain access to medicines by
AHPs [59-61].
2. Australasia
Similar shifts in health policy reform occurred, in a
comparable timeframe, in Australia, both at state and
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Provision of adequate care for an ageing population,
increased costs of medical technology (and new medica-
tions) and a crisis in recruitment and retention in
healthcare services were also relevant to Australian
healthcare [2,37]. Role boundary ‘flexibility’ and a recon-
figuration in the healthcare workforce became a central
facet of Australian health policy in the last decade, with
high level discussions on expanding the use of role sub-
stitution [37,54,55]. Discussions to emerge from the
Australian Health Minsters’ Conference of 2004 laid the
foundations for the National Health Workforce Strategic
Framework, highlighting the immediacy of concerns sur-
rounding health workforce shortages involving all of
Australia’s State, Territory and Federal Health Ministers
[37]. Similar concerns were expressed in the Australia
Institute of Health and Welfare reports at that time
[62]. In late 2005, the Australian Productivity Commis-
sion published its research report, ‘Australia’sH e a l t h
Workforce’, which further affirmed the need for role
flexibility and reform of traditional health provider roles
within the Australian health system [63]. However, the
recommendations in the report were largely ignored by
the Howard government, and the emphasis on role sub-
stitution was condemned by some elements within the
medical profession [64,65], despite significant support
within the mainstream press and the other sections of
the medical profession, along with consumers, nursing
and allied health professions [66-68].
The granting of authority for professions to incorpo-
rate drug prescribing into scope of practice in Australia
is complicated by separate and individual state and terri-
tory ‘drugs and poisons’ legislation. There is no over-
arching Commonwealth legislation to provide national
governance to prescribing, so any emerging profession
seeking prescribing amendments has needed to repeat
this process in every state and territory. Given the pecu-
liarities of individual state and territory legislation and
policy, non-medical professions have seen inconsistent
and variable formularies and governance develop across
the country, in contrast to the medical profession. It is
interesting to postulate that, in the light of the incidence
of adverse events relating to medical prescribing now
known, whether the regulators of an earlier era would
have conferred such broad prescribing rights even for
medicine.
However, funding for pharmaceutical provision in
Australia is achieved more simply at national level, via
the Pharmaceutical Benefits Scheme (PBS), and is a
Commonwealth government responsibility. Unlike the
UK system, there is no provision for AHP (or nurse
practitioners or doctors) prescribing from a local pri-
mary health care budget. Currently, approximately 80%
of prescriptions dispensed in Australia are covered by
the PBS scheme, which has only as recently as 2007
included a budget for prescriptions written by optome-
trists (though no other non-medically qualified profes-
sions, except dentistry), and is growing at a rate of 10-
15% annually [69].
Access to PBS funding for non-medical prescribing
groups remains the last barrier to equitable access to
prescription medications for patients of non-medically
qualified professions in Australia. This fact has not been
lost on the Australian Medical Association, which
remains staunchly opposed to non-medical prescribing
and PBS reforms, and argues that “t h es l i p p e r ys l o p et o
doctor pretenders is well and truly with us and although
there are a variety of pretenders with a variety of agen-
das, the successful agenda is pretty much always the
same...It is part of a much broader push towards task
substitution which the AMA has under the magnifying
glass...” [70]. As optometrists (and imminently nurse
practitioners) have statutory rights in all states and terri-
tories to prescribe restricted drugs under the PBS, it is
reasonable to suggest that only professions that have
successfully lobbied to amend all individual ‘drugs and
poisons’ legislations may be likely to receive Common-
wealth support for PBS benefits.
With the emergence of the Rudd Government into
federal government in 2007, the move towards a health
reform agenda became a key Labour policy at a national
level, although many of the policy initiatives had been
instigated by the previous administration. By 2008, the
Council of Australian Health Ministers had moved
ahead with this reform agenda, leading to the establish-
ment of the National Health Workforce Taskforce, and
a program for National Registration and Accreditation
for the majority of health professions. Combined with
these activities, the Rudd Government also announced
the establishment of system wide reviews of the health
system, including the National Health & Hospitals
Reform Commission and the National Primary Health
Care Strategy, to investigate options for review of the
health system.
In an unanticipated move, the Rudd Government
sought to pre-empt the outcomes of these reviews in
the 2009-10 federal Budget papers, by supporting regis-
tered nurse practitioners and midwives under the Medi-
care Benefits Schemes (MBS) and PBS Scheme, along
with making provision for public indemnity insurance
for midwives working within hospital settings. This
move was set to directly affect medical specialists, as
some existing MBS rebates (for services such as In Vitro
Fertilization and ophthalmology) were proposed for
reduction under these budget provisions - in order to
fund Commonwealth supported nurse practitioner and
midwife activities. In proposing this legislation, the
Health Minister, Nicola Roxon, commented that it was
Borthwick et al. Journal of Foot and Ankle Research 2010, 3:1
http://www.jfootankleres.com/content/3/1/1
Page 4 of 10“one of the centrepieces of the Rudd Government’s
workforce and primary health agenda” and, “al a n d m a r k
change for Australia’s nurses and midwives”[71]. The
Australian Medical Association, however, remained
opposed to the relevant Bill, proposing in a submission
that it be amended to include a requirement for medical
practitioners to be ‘gatekeepers’ to nurse practitioners
and midwives (thus excluding direct access from the
public), along with greater oversight and a ‘sunset’
clause [72].
The pattern of regulatory approval for New Zealand
podiatrists to access prescription medications bears many
similarities to that of the UK and Australia. In 1975
podiatrists obtained the right to administer the local
anaesthetic lignocaine, and since this time has been
reported by the registration authority to have been with-
out incident or deleterious outcome for any patient [73].
In 2002, the New Zealand New Prescribers Advisory
Committee was established under Section 8 of the Med-
icines Act 1981, to examine the role of prescribing by
health professions. The role of this committee was to
assess applications for extending limited independent
prescribing authority to new groups of health practi-
tioners in New Zealand and provide recommendations
to the Minister of Health, until it was disbanded in 2006
and taken over by the Ministry of Health.
Podiatry in the UK and Australasia
In both Australasia and the UK regulatory and legisla-
tive change has been gradual, but, as an AHP, podiatry
is acknowledged as fully involved in the administration,
access, supply, and prescription of prescription only and
pharmacy medicines. Indeed, key shifts in the role and
task domains within podiatry have evolved considerably
over the years, and have been directly related to access
to medicines.
In Britain, the immediate impact on podiatry of the
Medicines Act (1968) was to undermine normative prac-
tices, such as drug preparation, and bar access to local
anaesthetics [28]. The potential consequences raised
considerable anxiety across the profession [34]. Pro-
longed and difficult lobbying, extending over a four year
period, finally led to approval from the regulatory
a u t h o r i t yf o rt h eu s eo fl o c a l‘analgesic’ techniques, but
still did not enable legislative access to the medicines
[28]. Access was not fully obtained until 1980, following
an even longer period of lobbying [74]. Protracted nego-
tiations involving proposals and counter proposals were
marked by arguments over dosages and concentrations
of solutions, before agreement was finally reached [28].
Acquisition of rights to local anaesthesia opened the
door to the ongoing development of podiatric surgery,
which would clearly have had difficulty continuing with-
o u ta c c e s sr i g h t s[ 3 4 ] .A d m i n istration techniques were
also rapidly expanded, from simple toe anaesthesia
techniques, to full foot ankle block techniques, enabling
more complex procedures to be undertaken. Indeed,
most podiatric surgical procedures continue to employ
local anaesthesia methods [75].
The Thatcher Government, and the John Major
administration that followed, signalled a major shift in
healthcare policy, drawing on neo-liberal principles in
introducing deregulation and competitive tendering for
contracts in healthcare provision - a climate that engen-
dered the prospect of further change in the medicines
legislation [47,52]. The Society of Chiropodists can-
vassed its membership and collated evidence on the
extent and scope of medicines usage, in a bid to con-
struct a new, evidence-based, submission. The evidence,
drawn from referral patterns, pointed to a need for
access rights to certain oral antibiotic agents, notably
erythromycin and flucloxacillin as well as a defined and
limited range of other prescription only and pharmacy
medicines [76]. Even the regulatory body acknowledged
the request as legitimate, based as it was on evidence
drawn from the membership, noting that the referral
patterns for those prescription only medicines sought
(especially antibiotics) were ‘regular’. An enhanced role
for podiatrists in the field of medicines, as well as sur-
gery, was further acknowledged by the Department of
Health, in a joint NHS Chiropody Task Force publica-
tion of 1994 [77]. Considerable emphasis was placed on
the logic used to justify the proposed extensions, focus-
ing on easing the patient pathway and reducing GP
workload by preventing duplication of effort. In doing
so, the submission adhered to the principles of the
wider policy agenda, promoting a smooth, collaborative,
inter-professional approach to patient care [28]. In spite
of the evidence and logic, the resulting exemption order
reflected only limited success. Whilst access to several
more prescription only and pharmacy medicines was
granted, others, such as the antibiotics on the list, were
denied [78,79].
The formalisation of patient group directions (which
had been operating previously as group protocols)
added another tier to the options available to podiatrists
to access restricted category medicines. Podiatric sur-
geons probably benefited more than most in adopting
this mechanism within the National Health Service,
using it to gain access to a wide range of prescription
only medicines beyond the scope of the existing exemp-
tions, and thus further facilitating extensive foot surgical
procedures. In addition, it continued to appeal to the
modernisation agenda, establishing role flexibility and
thus enabling greater access to medicines by patients
[80]. Podiatrists specialising in diabetes care or rheuma-
tology were also increasingly able to access these
mechanisms in order to ease patient throughput in com-
plex multi-professional hospital clinics, reducing
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development of new skills, such as intra-articular injec-
tions. Patient group directions, were, however, locally
devised and agreed, and were thus only possible to
enact with the co-operation of those physicians willing
to engage with the process, leading to disparities across
the country. AHP prescribing was further acknowledged
by the introduction of enabling legislation in the form
of the Health and Social Care Act (2001), acting as pri-
mary legislation, and thus superceding key sections of
the Medicines Act (1968) [81].
Many physicians were highly supportive of expanding
the role boundaries of allied health workers, including
podiatrists, most notably within the diabetes fraternity.
Some even suggested a role for podiatrists in the treat-
ment and management of hypertension and insulin dose
alteration [82]. However, universal support is lacking,
and the use of patient group directions is widely viewed
as a measure likely to be replaced by a more robust sys-
tem in due course, such as independent prescribing. In
some measure this more robust process has already
been established as ‘supplementary prescribing’,
extended to physiotherapists, radiographers and podia-
trists in April 2005 [83]. However, it has received mixed
responses from within the profession, being effective in
multi-professional environments, but less effective in
independent practice, especially in podiatric surgery,
possibly accounting for the limited uptake [84]. Indeed,
by 2008 only 64 podiatrists had become supplementary
prescribers [85]. It is, in part, possible to account for
this finding, as opportunities to undertake training in
supplementary prescribing are ‘rationed’ by employers,
who are required to fund places and provide
mentorship.
AHP ‘supplementary prescribing’ also has the disad-
vantage that it is dependent upon co-operative physi-
cians, who are essential as both mentors in training and
as independent prescribers in practice. Without an
authorised initial diagnosis and clinical management
plan it is not possible to utilise a supplementary prescri-
ber. Nevertheless, although it was originally envisaged
that the supplementary prescribing role would consist of
monitoring and adjusting existing prescriptions, in prac-
tice it has proved sufficiently flexible to enable the care
of acute medical emergencies in patients with chronic
illness (such as infected ischaemic ulcers in cases of dia-
betes) [85].
In 2006 a new exemption list for podiatrists was intro-
duced reflecting further the impact of health policy
modernisation and the diminishing authority of medi-
cine over prescribing. It included full access to the anti-
microbials amoxicillin, flucloxacillin and erythromycin,
without any specification on dosage or route of adminis-
tration [86]. It affords podiatrists in general practice the
ability and scope to deploy antimicrobials to combat
infections and to access adrenalin for use in emergency
circumstances. Reflecting on the failure of repeated pre-
vious attempts to gain access to these medicines, the
2006 exemption particularly illustrates the new climate
of change, and the growing acceptance of the reality of
workforce redesign and role transfer in the sphere of
medicines.
Most recently, in July 2009, the UK Department of
Health published a report for the Chief Health Profes-
sions Officer, examining the case for extending prescrib-
ing and medicines supply mechanisms for the allied
health professions [85]. It concluded that there was a
‘strong case for progression to independent prescribing
for physiotherapists and podiatrists’, and included key
recommendations that further work be undertaken to
establish independent prescribing for these two groups.
Independent prescribing for podiatrists, whilst not
directly comparable to medical or dental prescribing, is,
seemingly, very much on the agenda. The change of cli-
mate is consistent with the need to develop a workforce
capable of taking on new, expanded roles previously
within the exclusive domain of medicine [87,88]. It is
nevertheless intriguing to note that there remains an
important distinction between independent prescribing
for the AHPs, and medical (or dental) prescribing.
Unlike the latter, the former does not include access to
unlicensed medicines or controlled drugs (the equivalent
of S8 in Australia). At face value this may seem rela-
tively unimportant, yet podiatrists continue to use, very
widely, at least one agent that until recently was
regarded by the Medicines and Healthcare Products
Regulatory Agency as an unlicensed medicine - specifi-
cally liquefied phenol, used in toenail ablation techni-
ques. In July this year the Medicines and Healthcare
Products Regulatory Agency published a statement
asserting that, as it “does not have a primary mode of
action which is pharmacological, metabolic or immuno-
logical it falls outside the definition of a medicinal pro-
duct”. As a result, providing the product is not
marketed with medicinal claims, it is no longer subject
to medicines legislation. In combination, these recent
changes reflect the pace of the broader workforce trends
towards redesign, role substitution and enhanced
flexibility.
Like the UK, administration rights to local anaesthetic
agents (Schedule 4 drugs) became the first marker of
change for podiatry in Australia, facilitating the same
advances in practice and similar challenges from the
medical profession [37]. Recent data shows that each
State possesses similar access to a range of local anaes-
thesic agents, achieved over a comparable timeframe to
that in the UK, where South Australia appears the most
liberal, and (up until recently) Queensland the most
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to state, only in South Australia, Western Australia and,
more recently, Victoria and Queensland, are access,
administration, supply or prescription rights to
restricted or controlled medicines available (Schedule 4
or 8 medicines), though these are largely restricted to
the relatively small workforce of qualified podiatric
surgeons.
It is notable that since the original legislation, only
South and Western Australia have seen subsequent
additions and modifications. Furthermore, the Adverse
Drug Reactions Advisory Committee has indicated that
there is “no known pattern of adverse reactions relating
to podiatric prescribing”, although the Australian Medi-
cal Association in Victoria openly disputed this, indicat-
ing that “the suggestion that there has been no adverse
side effects to medications prescribed by podiatrists
reflects the hubris of many non-medical professions
who seek prescribing rights...” [90]. This criticism does
raise the suggestion for the profession and its governing
authorities to develop, or integrate into existing,
adverse-event reporting pathways, and for public data to
be collected on podiatric prescribing in Australia.
In Australia, access to medicines is governed by a
‘drugs & poisons’ authority in each State and Territory,
although the actual ‘scheduling’ of medicines is a Com-
monwealth (Federal) responsibility, undertaken by the
National Drugs & Poisons Schedule Committee (a
branch of the Therapeutic Goods Administration and
equivalent to the UK’s Medicines and Healthcare Pro-
ducts Regulatory Agency) in combination with the Com-
monwealth Department of Health and Ageing [37,39].
Specific regulation on the mechanisms for the supply,
administration or prescription of ‘restricted and con-
trolled’ drugs is contained in a number of State & Terri-
tory ‘drugs and poisons’ legislation (for eg. Poisons Act
1933; Poisons and Drugs Act 1978; Drugs of Depen-
dence Act (1989). Unlike the UK, there is no single
over-arching medicines legislation, although currently
plans to introduce a uniform scheduling of medicines to
effect ‘harmonisation’ across Australia and New Zealand
are underway [91]. A new Medicines and Poisons Bill
(2006) is currently under consultation, and will “not
change non-medical prescribing rights” but will grant
“consideration...to a proposal to grant ACT podiatrists
limited prescribing rights” [39].
In South Australia rights to a limited list of restricted
medicines (other than local anaesthesia) were granted in
1989, and extended in 1996, largely limited to qualified
podiatric surgeons. Similar changes were established in
Western Australia in 1995, where podiatrists with a rele-
vant Master’s degree were able to apply to supply (but,
importantly not prescribe) a narrow range of restricted
drugs such as antibiotics and analgesics.
In Queensland, amendments to the Health (Drugs &
Poisons) Regulation 1996 came in 2006 to allow recog-
nised ‘surgical podiatrists’ (who hold Fellowship with the
Australasian College of Podiatric Surgeons) to prescribe,
supply or administer a limited formulary of Schedule 4
and one Schedule 8 drug. Importantly, Queensland then
is the only Australian jurisdiction to allow authorised
(surgical) podiatrists to prescribe a ‘controlled’ S8 drug
of dependence (oxycodone), for managing postoperative
pain. Additionally, the amendments allowed for general
podiatrists to access adrenaline (in a pre-loaded device)
for the emergency management of anaphylaxis, though
curiously not for use in combination with local anaes-
thesia (as it is in several other Australian jurisdictions),
unless the registrant was an endorsed ‘surgical podia-
trist’. Additional plain preparations of several other local
anaesthetic agents were also made available for adminis-
tration by general podiatry registrants.
It is in Victoria that the most recent, and advanced
rights have been attained. Under the terms of the Health
Professions Registration Act (2005) and the 2007 Regu-
lation amendments to the Drugs, Poisons and Con-
trolled Substances Act 1981, the Podiatrists’ Registration
Board had been given authority to determine which
Schedule 2,3 and 4 medicines may be possessed, used,
sold or supplied by its registrants following approval by
the Health Minister. As a result, the Podiatrists’ Board
was empowered to create a subset of registrants known
as ‘authorised prescribers’. The Acts do not specify the
particular form of undergraduate or postgraduate train-
ing, leaving these decisions to the Podiatrists Board, via
advice from its own Prescribing Practice Advisory Com-
mittee and key stakeholders, and in consultation with
the Minister. Most significantly, the Schedule 2, 3 and 4
drugs approved in Victoria are available for use by all
suitably qualified podiatrists, and not just podiatric sur-
geons, as is predominantly the case elsewhere. Final
approval of the initial formulary was given by the Health
Minister in June 2009.
Under the current process of National Registration &
Accreditation, local state and territory health profes-
sional registration boards will be disbanded and replaced
by national authorities. As such, the Podiatry Board of
Australia was constituted in 2009, with the task of tak-
ing over the administration of registration and regula-
tion of standards of practice for all Australian
podiatrists in July 2010. Under the requirements of the
Health Practitioner Regulation (Administrative Arrange-
ments) National Law Act 2008, the Board has already
begun consultation on the mechanisms for the arguably
overdue implementation of national standards for podia-
tric prescribing within Australia, to be submitted for
approval by the Australian Health Workforce Ministerial
Council [92]. However, the move to any national
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the jurisdiction inconsistencies of local drugs and poi-
sons legislation in different states and territories, and a
uniform approach will be a highly desirable long term
solution to addressing this problem.
In 2005 a joint application was made by the Podia-
trists Board of New Zealand and the New Zealand
Society of Podiatrists to the New Prescribers Advisory
Committee for podiatrists to be recognised as “desig-
nated prescribers,” in the Regulations under the Medi-
cines Act 1981[73]. As part of this application, the
proposed curriculum for New Zealand registrants
wishing to potentially become a ‘designated prescriber’
was put forward from the Auckland University of Tech-
nology in the form of a Postgraduate Diploma of Health
Science modelled on the nurse practitioner curriculum.
Under the terms of the Health Practitioners Compe-
tence Assurance Act 2003, the Podiatrists Board of New
Zealand was granted the authority to determine Scopes
of Practice for the profession. In doing so, it determined
a new category of advanced scope practitioner known as
a ‘podiatric prescriber’ [73]. However, as at the end of
2007, the Podiatrists Board of New Zealand announced
that NPAC had accepted its submission in principle,
pending final modifications to the proposed monitoring
processes and final list of medications, prior to activat-
ing the ‘podiatric prescriber’ category of registration
[93]. Table 1 summarises the varying and inconsistent
nature of the various requirements for endorsed podia-
tric prescribers in Australasia.
Discussion
It is clear that the recent changes in prescribing rights
for AHPs in both the UK and Australasia reflect the
impact the forces of neo-liberalism, new public manage-
ment and economic rationalism have had on medical
autonomy in the arena of prescribing. The trend
towards workforce flexibility and role substitution has
led to enhanced roles for the AHPs, and this has been
extended to the prescribing arena, which, of course, is
one of the most distinctive task jurisdictions that medi-
cine has traditionally controlled. By examining the case
exemplar of podiatry, it has been possible to trace the
earlier attempts, from the 1960s and 1970s, of this
group to secure a foothold in the area of medicines, and
to contrast this early paucity of success with later devel-
opments. Indeed, the rapidity of change in the last dec-
ade bears no resemblance to the tortuous and near
futile efforts of a decade earlier to achieve meaningful
prescribing rights.
Yet, opposition by the medical profession has been
fairly consistent in both the UK and Australasia. Whilst
this opposition may have been moderated in the UK, in
the light of health policy reform, it is much less
obviously so in Australia [94]. Although, as recent
changes enabling the independent prescribing status of
some nurses and pharmacists suggests, non-medical pre-
s c r i b i n gm a yb ea ni n t e g r a la nd irreversible part of the
changing landscape of modern professionalism, it is also
premature to suggest that the authority of medicine in
influencing and determining the content of work of
o t h e rh e a l t hp r o f e s s i o n si sa ta ne n d .N e wm o d e so f
prescribing available to the majority of AHPs remain in
several ways subject to the authority of medicine (such
as patient group directions or supplementary prescrib-
ing, which require the written authority of the doctor,
or the doctor’s mentorship, or delegation from the doc-
tor once the diagnosis and management plan has been
decided).
In both the UK and Australasia, allied health profes-
sionals access, administration and prescribing rights
have been subject to limitation - either in the ways
described above, or simply in the limited lists or formul-
aries that require extensive effort and legislative
approval to modify. Only in independent forms of pre-
scribing is clinical or technical autonomy fully exercised
in the prescribing field, although amendments and stat-
utory instruments altering specific professions access
Table 1 Summary of statutory requirements for drug prescribing by podiatrists in Australasia (as at 2009)
Jurisdiction Educational requirements for prescribing Governance level
Victoria Recent undergraduate podiatry degree (2003 onwards from Latrobe University), with Board
approved postgraduate pharmacology studies and clinical experience
[interstate or less recent graduates are required to undertake additional core content studies
and clinical experience]
Least restrictive
New Zealand A postgraduate qualification as determined by the Podiatrists Registration Board of New
Zealand, or equivalent overseas qualification
Western Australia Master’s degree with advanced pharmacology core unit
South Australia Fellowship of the Australasian College of Podiatric Surgeons
Queensland Fellowship of the Australasian College of Podiatric Surgeons + additional Board requirements Most restrictive
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degree of autonomy - yet these are difficult to obtain
and usually require lengthy periods of lobbying in
advance. Also significant in the broader picture is the
extent to which educational advances within the profes-
sion have enabled further rights and a greater scope of
prescribing practice, acknowledged by regulators in both
the UK and Australasia. In Australia, there is little
doubt that the additional and extensive training required
to practice as a podiatric surgeon underpinned wider
access to restricted medicines since the 1980s.
Conclusion
In constructing a chronological account of ‘prescribing’
within the profession of podiatry in both Australasia
and the UK, grounded in a socio-historical context, it
has been possible to demonstrate the influence of health
policy drivers at work in determining change, and to
highlight, therefore, the rapidity and extent of the
changes within the last decade. The reality of workforce
redesign is amply illustrated in the case of AHP pre-
scribing, and constitutes one facet of the broad policy
agenda intended to ensure a new health service provi-
sion, fit for purpose in the 21
st century. Clearly, the
AHPs must rise to the challenge.
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